Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
FDC Limited is a leading pharmaceutical company in India, engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs). It is particularly noted for its expertise in oral rehydration solutions, energy drinks, antibiotics, and ophthalmic therapies.
The company has expanded its global footprint through two wholly-owned subsidiaries in the USA and UK, and a joint venture in South Africa. FDC is also setting up advanced manufacturing plants to enhance its production capabilities.
FDC has a strategic focus on innovation with ongoing projects like recombinant Granulocyte Colony Stimulating Factor and third-generation thrombolytes. It has received multiple regulatory approvals, including those from the US FDA and European agencies.
The company has executed multiple buybacks and mergers to optimize its equity structure, with significant acquisitions in South Africa, making Fair Deal Corporation Pharmaceutical SA (Pty) Ltd a subsidiary.
In recent years, FDC has diversified its nutraceuticals products, launching multiple energy and immunity-boosting drinks, aligning with modern health and wellness trends. New product launches and expansion into emerging markets continue to drive growth.
Pharmaceuticals & Biotechnology
Pharmaceuticals
5,936 Cr
Low Risk
25.0
32.2
3.3
2.4
528.30
314.75
Sales CAGR
Profit CAGR
ROE
ROCE
FDC Ltd (FDC) is currently trading at 359.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
FDC Limited is a leading pharmaceutical company in India, engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs). It is particularly noted for its expertise in oral rehydration solutions, energy drinks, antibiotics, and ophthalmic therapies. The company has expanded its global footprint through two wholly-owned subsidiaries in the USA and UK, and a joint venture in South Africa. FDC is also setting up advanced manufacturing plants to enhance its production capabilities. FDC has a strategic focus on innovation with ongoing projects like recombinant Granulocyte Colony Stimulating Factor and third-generation thrombolytes. It has received multiple regulatory approvals, including those from the US FDA and European agencies. The company has executed multiple buybacks and mergers to optimize its equity structure, with significant acquisitions in South Africa, making Fair Deal Corporation Pharmaceutical SA (Pty) Ltd a subsidiary. In recent years, FDC has diversified its nutraceuticals products, launching multiple energy and immunity-boosting drinks, aligning with modern health and wellness trends. New product launches and expansion into emerging markets continue to drive growth.
Over the past 52 weeks, FDC Ltd has traded between a low of ₹314.75 and a high of ₹528.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
FDC Ltd has a market capitalization of approximately 5,936.06. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
FDC Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.03 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 5,936.06 Cr, FDC Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
FDC Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of FDC Ltd is 25.03. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Investor Presentation
Q2 FY24
Investor Presentation
Q3 FY23
Investor Presentation
Q2 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY23
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY22
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY17
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY17
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY16
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Bearish
5
Neutral
5
Bullish
4
Bearish
20
Neutral
5
Bullish
21
Bearish
15
Neutral
0
Bullish
17
Postal Ballot Notice
FDC Limited has issued a postal ballot notice seeking shareholder approval to appoint Mr. Kishore Mukund Saletore as an Independent Director for five years (Apr 1, 2026–Mar 31, 2031); remote e‑voting: Apr 28–May 27, 2026; results by May 29, 2026.
Independent Director Appointment
Board approved seeking shareholders' approval via postal ballot for appointment of Mr. Kishore Saletore as Independent Director for 5 years from Apr 1, 2026 to Mar 31, 2031; e-voting Apr 28–May 27, 2026, results by May 29, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
603.60 | 7,387 Cr | 47.19 | 9.00 | 0.00 | 20.63 | 23.80 | 17.20 | ||
362.30 | 7,210 Cr | 0.26 | 5.74 | 0.29 | 28.06 | 37.35 | 19.22 | ||
701.00 | 6,405 Cr | 29.75 | 3.13 | 0.71 | 11.72 | 12.99 | 6.54 | ||
333.35 | 5,936 Cr | 25.03 | 2.44 | 1.37 | 9.27 | 12.51 | 7.51 | ||
617.80 | 4,994 Cr | 26.80 | 4.62 | 0.16 | 16.86 | 22.47 | 15.40 | ||
123.30 | 4,673 Cr | -14.93 | 0.00 | 0.00 | 77.47 | -181.73 | -83.09 | ||
1308.90 | 4,426 Cr | -60.50 | 5.96 | 0.06 | -19.58 | -9.69 | -11.97 | ||
| Median: 7 Co. | — | 603.60 | 5,936 Cr | 25.03 | 4.62 | 0.16 | 16.86 | 12.99 | 7.51 |
